Compare NKTX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | ARAY |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.7M | 170.1M |
| IPO Year | 2020 | 2007 |
| Metric | NKTX | ARAY |
|---|---|---|
| Price | $1.81 | $1.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $13.25 | $4.50 |
| AVG Volume (30 Days) | 684.9K | ★ 1.2M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $450,902,000.00 |
| Revenue This Year | N/A | $5.70 |
| Revenue Next Year | N/A | $4.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $1.31 | $0.91 |
| 52 Week High | $3.16 | $2.95 |
| Indicator | NKTX | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 35.59 |
| Support Level | $1.77 | $0.99 |
| Resistance Level | $1.93 | $1.12 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 30.00 | 40.33 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.